Show simple item record

The next frontier: Fostering innovation by improving health data access and utilization

dc.contributor.authorOye, Kenneth A.
dc.contributor.authorJain, Gagan
dc.contributor.authorAmador, M.
dc.contributor.authorArnaout, R.
dc.contributor.authorBrown, J. S.
dc.contributor.authorCrown, W.
dc.contributor.authorFerguson, J.
dc.contributor.authorPezalla, E.
dc.contributor.authorRassen, J. A.
dc.contributor.authorSelker, H. P.
dc.contributor.authorTrusheim, M.
dc.contributor.authorHirsch, Gigi
dc.date.accessioned2015-10-29T14:32:58Z
dc.date.available2015-10-29T14:32:58Z
dc.date.issued2015-08
dc.date.submitted2015-07
dc.identifier.issn00099236
dc.identifier.issn1532-6535
dc.identifier.urihttp://hdl.handle.net/1721.1/99499
dc.description.abstractBeneath most lively policy debates sit dry-as-dust theoretical and methodological discussions. Current disputes over the EU Adaptive Pathways initiative and the proposed US 21st Century Cures Act may ultimately rest on addressing arcane issues of data curation, standardization, and utilization. Improved extraction of inform ation on the safety and effectiveness of drugs-in-use must parallel adjustments in evidence requirements at the time of licensing. To do otherwise may compromise safety and efficacy in the name of fostering innovation.en_US
dc.language.isoen_US
dc.publisherWiley Blackwellen_US
dc.relation.isversionofhttp://dx.doi.org/10.1002/cpt.191en_US
dc.rightsCreative Commons Attribution-Noncommercialen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/en_US
dc.sourceWileyen_US
dc.titleThe next frontier: Fostering innovation by improving health data access and utilizationen_US
dc.typeArticleen_US
dc.identifier.citationOye, KA, G Jain, M Amador, R Arnaout, JS Brown, W Crown, J Ferguson, et al. “The Next Frontier: Fostering Innovation by Improving Health Data Access and Utilization.” Clin. Pharmacol. Ther. 98, no. 5 (September 10, 2015): 514–521.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Center for Biomedical Innovationen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Political Scienceen_US
dc.contributor.mitauthorOye, Kenneth A.en_US
dc.contributor.mitauthorJain, Gaganen_US
dc.contributor.mitauthorHirsch, Gigien_US
dc.relation.journalClinical Pharmacology & Therapeuticsen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsOye, KA; Jain, G; Amador, M; Arnaout, R; Brown, JS; Crown, W; Ferguson, J; Pezalla, E; Rassen, JA; Selker, HP; Trusheim, M; Hirsch, Gen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-9811-8415
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail
Name:
Oye_et_al-2015-Clinical_Pharma ...
Size:
557.3Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record